The Laboratory for Myasthenia Gravis (MG) Research is dedicated to “a world without MG.” To achieve that goal the Laboratory has a broad-based research program dedicated to understanding the pathogenesis of MG with a focus on development of new therapeutics. Our therapy development program spans pre-clinical programs, clinical trials, and biomarker discovery. We work closely with the clinicians of the GW Medical Faculty Associates Myasthenia Gravis Center and investigators across the United States and the world in academics and industry.

Linda L. Kusner, Ph.D. directs the laboratory and is Professor of Pharmacology and Physiology. She has been a close collaborator of Dr. Kaminski’s for many years. Their complementary expertise in appreciation of the inadequacy of present therapies and the challenges in linking animal to human studies makes for a powerful team in therapeutic development.